The findings, based on an analysis of records from 2.5 million VA patients, support much of what scientists already suspected ...

Biopharma executives shared their thoughts on the potential impacts of the new administration; Annalee Armstrong recaps JPM ...

Average price per insulin unit dropped 42%, from $0.33 in 2019 to $0.19 in mid-2024 -- the lowest average recorded in a ...

The benefits of taking GLP-1 agonists seem to outweigh the risks, at least when taken for approved uses, according to an ...

A high dose of Novo Nordisk’s obesity drug Wegovy led patients to lose substantial weight in a clinical trial, but still less ...

Time for your weekly edition of the Defector Funbag. Got something on your mind? Email the Funbag. And buy Drew’s book, The ...

New Rule Seeks to Expand Medicare and Medicaid Coverage of Weight Loss Drugs. The Biden Administration has proposed a new ...

A new study from the Department of Veteran Affairs, published in Nature Medicine, found that GLP-1 weight loss drugs including Mounjaro, Ozempic, Wegovy and Zepbound, may offer benefits beyond weight ...

Wegovy also can be prescribed to reduce the ... The proposed rule, which requires a lengthy process of collecting public comments and review, would need to be finalized after President-elect ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

it tracks and reviews side effects of the medication. If you’d like to notify the FDA about a side effect you’ve had with Wegovy, visit MedWatch. For some people, Wegovy can cause an allergic ...